DNA X enters securities purchase agreement for $8.1M private placement of Series B Preferred Stock

DNA X, Inc.

DNA X agreed to issue 1,346,531 shares of Series B Convertible Preferred Stock at $6.00 per share to DNA Holdings Venture, Inc. for aggregate $8.1M.
The $8.1M consists of $5.0M in cash and cancellation of $3.1M convertible promissory note issued in May 2026.
DNA Holdings is an entity associated with board member Scott Walker and holds >5% of DNA X common stock.
The Series B Preferred Stock is non-voting and automatically converts to common stock upon stockholder approval.
DNA X also entered into a registration rights agreement for resale of common shares issuable upon conversion.

item 1.01 item 5.03 item 3.02 item 3.03 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.